Overview

This trial is active, not recruiting.

Conditions quality-adjusted life years, epidemiology, public health
Sponsor Centre Hospitalier Universitaire de la Réunion
Start date January 2014
End date December 2016
Trial size 800000 participants
Trial identifier NCT02905500, 2013/CHU/AVIRON

Summary

AVIRON study aims at estimating the burden of various causes of death and morbidity in the Reunion Island population.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model ecologic or community
Time perspective cross-sectional

Primary Outcomes

Measure
Incidence of years of life lost or lived with disabilities
time frame: 3 years
Prevalence of years of life lost or lived with disabilities
time frame: 3 years

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - The whole population of Reunion Island Exclusion Criteria: - People not living in Reunion Island

Additional Information

Official title Estimation Des années de Vie ajustées Sur l'incapacité à La réunion et Comparaison à la France métropolitaine et Aux Pays de la Zone Océan Indien
Description The identification of health priorities on a given territory is a major field of the research in Public health. The World Health Organization leads since the 1990s the "Global Burden of Disease" study. This study has for objective to estimate the burden of various causes of death and morbidity in a given population. It defines a standardized measure allowing the comparisons between the various countries. The measure developed internationally is the Disability-adjusted life year (DALY). For the Indian Ocean zone, the international study provides values of DALYs for Madagascar, Seychelles and Mauritius. The estimation of DALYs for Reunion Island are based on data of mainland France and does not take into account specificities from Reunion Island. To better define Public health priorities, it seems essential to decline this measure at the regional level.
Trial information was received from ClinicalTrials.gov and was last updated in September 2016.
Information provided to ClinicalTrials.gov by Centre Hospitalier Universitaire de la Réunion.